| 2002 |
Neurabin I (PPP1R9A) recruits active PP1 via a PP1-docking sequence (457)KIKF(460); mutation of this motif or pharmacological PP1 inhibition abolishes neurabin I-induced filopodium formation and restores stress fibers, establishing that the neurabin I/PP1 complex controls actin rearrangement and spine morphology. |
Immune complex phosphatase assays, GFP-fusion cell imaging, site-directed mutagenesis of PP1-binding motif, okadaic acid/calyculin A treatment in Cos7, HEK293, and hippocampal neurons |
Molecular and cellular biology |
High |
12052877
|
| 2002 |
The N-terminal F-actin-binding domain of neurabin I dictates its localization to the actin cytoskeleton and promotes disassembly of stress fibers, while deletion of the C-terminal coiled-coil and SAM domains abolishes dimerization and induces filopodium extension. |
GFP-fusion domain deletion analysis and fluorescence microscopy in Cos7, HEK293, and hippocampal neurons |
Molecular and cellular biology |
High |
12052877
|
| 2002 |
PKA phosphorylation of neurabin I at serine-461 (within the PP1-binding motif) impairs PP1 binding, and in vitro studies showed the actin-binding domain attenuates PKA phosphorylation of neurabin I; p70S6K is excluded from neurabin I/PP1 complexes and requires displacement of PP1 for its own recruitment to neurabin I. |
In vitro kinase assays, co-immunoprecipitation, phospho-site mutagenesis (S461E), immune complex assays |
Molecular and cellular biology |
High |
12052877
|
| 1999 |
Neurabin I binds and inhibits PP1 (Ki = 2.7 nM) via residues 456-460; PKA phosphorylates neurabin I at serine-461 (within the PP1-binding motif), and this phosphorylation significantly reduces PP1 binding and inhibitory potency (~35-fold reduction with S461E phosphomimetic mutant). |
Overlay assay, yeast two-hybrid, co-precipitation, co-immunoprecipitation, GST-fusion PP1 inhibition assay, in vitro PKA kinase assay, HPLC-MS phosphosite identification, S461E mutagenesis |
Biochemistry |
High |
10504266
|
| 2002 |
Neurabin I preferentially recruits PP1gamma1 and PP1alpha isoforms over PP1beta from brain extracts; sequences flanking the conserved PP1-binding motif and C-terminal sequences unique to PP1 isoforms both contribute to this selectivity. In PP1gamma null mice, neurabins show enhanced association with PP1alpha but not PP1beta. |
Immunoprecipitation from rat brain extracts, in vitro binding assays with recombinant peptides and chimeric neurabins, PP1/PP2A chimera assays, immunoprecipitation from PP1gamma knockout mouse brain |
The Journal of biological chemistry |
High |
12016225
|
| 2007 |
Cdk5 directly phosphorylates neurabin I and controls its association with F-actin; mutation of the Cdk5 phosphorylation site reduces the phenotypic consequences of neurabin I overexpression (altered neuronal morphology and migration defects) both in vitro and in vivo, and neurabin I expression levels affect Rac1 activation in neurons. |
In vitro kinase assay, site-directed mutagenesis of Cdk5 site, gain/loss-of-function in cortical and hippocampal neurons, in utero electroporation, Rac1 activation assay |
Molecular biology of the cell |
High |
17699587
|
| 2006 |
Neurabin I directly interacts with the neuronal GTPase Rac3 (identified by yeast two-hybrid), colocalizes with Rac3 at growth cones, and is required for Rac3-induced neuritogenesis; neurabin I mediates this process by anchoring Rac3 to growth cone F-actin, as a Rac3-binding domain deletion mutant fails to rescue neuritogenesis. |
Yeast two-hybrid, co-fractionation, co-localization by light microscopy, antisense oligonucleotide knockdown, rescue with wild-type vs. Rac3-binding domain mutant neurabin I |
Molecular biology of the cell |
High |
16525023
|
| 1999 |
Bau, a splice form of neurabin I (PPP1R9A) lacking actin- and p70S6K-binding domains, interacts with the tumor suppressor Bin1 via its U3 region, localizes to the nucleus and cytosol, and suppresses oncogene-mediated cell transformation and tumor cell growth. |
Yeast two-hybrid identification, co-immunoprecipitation, subcellular fractionation/localization, transformation suppression assay |
Cell adhesion and communication |
Medium |
10427963
|
| 2018 |
Neurabin I is atypically hyper-N-glycosylated at ASN1277, rendering it immunogenic and acting as a B-cell receptor autoantigen that drives BCR pathway activation and proliferation in primary CNS lymphoma cells. |
BCR immunoprecipitation/antigen identification, BCR transfection into lymphoma cell lines, BCR pathway activation assays, epitope-toxin conjugate cytotoxicity assay |
Blood |
Medium |
30249786
|